SFX by Ex Libris Inc.

Title:	AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Source:	Nature [0028-0836] Gardner, M R yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Haigwood, Nancy L. "HIV: Tied down by its own receptor." Nature 519.7541 (2015): 36-37.
description	2.	fire, A. "potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans." Nature 391.6669: 806-811.
description	3.	Cuesta, A. "Multivalent antibodies: when design surpasses evolution." Trends in biotechnology 28.7 (2010): 355-362.
description	4.	Lee,, Ha Youn, H. "Modeling sequence evolution in acute HIV-1 infection." Journal of theoretical biology 261.2 (2009): 341-360.
description	5.	Sullivan, N. "Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies." Journal of virology 72.8 (1998): 6332-8.
description	6.	Elbashir, S M M. "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells." Nature 411.6836 (2001): 494-498.
description	7.	Hannon, G. "RNA interference." Nature 418.6894 (2002): 244-251.
description	8.	Caplen, N J J. "Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems." Proceedings of the National Academy of Sciences of the United States of America 98.17 (2001): 9742-7.
description	9.	Montgomery, M K K. "RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans." Proceedings of the National Academy of Sciences of the United States of America 95.26 (1999): 15502-7.
description	10.	Hamilton, A J J. "A species of small antisense RNA in posttranscriptional gene silencing in plants." Science 286.5441 (1999): 950-2.
description	11.	Miller, Franklin G. "Varieties of Standard-of-Care Treatment Randomized Trials: Ethical Implications." JAMA: the Journal of the American Medical Association 313.9 (2015): 895-6.
description	12.	Ni, G. "Manipulating IL-10 signalling blockade for better immunotherapy." Cellular immunology 293.2 (2015): 126-129.
description	13.	Balazs, L. "Antibody-based protection against HIV infection by vectored immunoprophylaxis." Nature 481.7379 (2011): 81-84.
description	14.	Tomaras, Barton D. "HIV-1-specific antibody responses during acute and chronic HIV-1 infection." Current opinion in HIV and AIDS 4.5 (2009): 373-379.
description	15.	Flexner, C. "HIV drug development: The next 25 years." Nature reviews. Drug discovery 6.12 (2007): 959-966.
description	16.	Lim, D. "Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells." Journal of biotechnology 153.3-4 (2011): 77-85.
description	17.	Li, Q. "Glycerol monolaurate prevents mucosal SIV transmission." Nature 458.7241 (2009): 1034-8.
description	18.	Weisser, Nina E. "Applications of single-chain variable fragment antibodies in therapeutics and diagnostics." Biotechnology advances 27.4 (2009): 502-20.
description	19.	McMichael, Andrew J. "The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection." The Journal of experimental medicine 206.6 (2009): 1253-72.
description	20.	Li, J. "Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection." The Journal of experimental medicine 206.6 (2009): 1273-1289.